-
5 – Common Questions About Generic Drugs
How they’re different from brand-name drugs Chances are, if you’ve ever had a prescription filled at a pharmacy, you’ve probably consumed a generic drug. Nearly 9 out of 10 prescriptions filled in the U.S. today are generic drugs, according to the Food and Drug Administration. Yet many people feel confused about what they are, where…
-
Defining Biosimilars in Oncology: Priyanka Singh Pharma Entrepreneur
“We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products”! WHAT IS Biosimilars: Unlike generic chemical medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical to the originator biologic. They…
-
Taj Pharma healthcare mission in Russia and CIS countries by 2020
ТАДЖ ФАРМА medicines are dedicated to treat complex health conditions such as renal insufficiency, Cancer, Hepatitis C and HIV infections and other disorders. TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded Pharmaceuticals Company; it combines a world-class research and development center, ultra-modern pharmaceutical and generics manufacturing facilities, as well as preclinical…
-
Estonian health care an unique comprehensive data integrated system
Healthcare in Estonia is supervised by the Ministry of Social Affairs and funded by general taxation through the National Health Service. Electronic health record Estonia is a pioneer in the use of Electronic health records because when general practice was moved out of hospitals in 1998 the records were kept in the hospitals, so GPs…
-
Reasons for failure in startups business by Ms. Priyanka Singh
Here are the top most reasons why businesses fail and tips for avoiding them. According to statistics published by the Small business administration experience and statics, seven out of ten new employer establishments survive at least two years and 51 percent survive at least five years. This is a far cry from the previous long-held…
-
Health and wealth; the pursuit of humankind – Ms. Priyanka Singh
Priyanka Singh (popular as ‘Ms Singh’ within her peer group), is the Director of Taj Pharma Group companies, India. She is also the founder of an Agro company “Taj Agro Products” which deals in commodity sector and Food Industry in India and abroad. Ms Singh played a pivotal role in the decade transformation journey of…
-
MENA region- Pharma Products Exports – Ms. Priyanka Singh Views – Director Taj Pharma Group
Given your expertise in the MEA region, how would you assess the present state of the GCC market and across the wider region? The MENA market faced a slowdown last year, primarily driven by the oil crisis in key countries such as Saudi Arabia, and Algeria, and currency devaluation and economic crises in other countries,…
-
Generics Medicines Initiative Ms. Priyanka Singh Director Taj Pharma
Generics Medicines Initiative: The Beginning: We have seen a lot of vertical integration in health care, typically different health care providers merging, or providers and health plans. But integration of providers into pharmaceutical manufacturing setting aside a little compounding — is pretty unprecedented. Well I would say necessity is the mother of invention, right? This…
-
Compliance and Competitiveness in Indian Pharmaceuticals Industry by Ms. Priyanka Singh Director Taj Pharma Group
Compliance and Competitiveness in Indian Pharmaceuticals Industry: by Ms. Priyanka Singh Director Taj Pharma Group The word “compliance” in India took on a whole new meaning in 2012 when key Indian Pharma Products exports pushed to USA and European Markets without much apprehensions. That new status, known as the “Generalised System” of Preferences plus is…
-
Education is an essential for embracing society and polishing entrepreneurship skill
Entrepreneurship and innovation are the engines of any economy. Most businesses in Asia are inherited. There’s very little entrepreneurship. Encouraging economic growth involves thinking outside the box and putting infrastructure in place for entrepreneurs to contribute to society. All new businesses at first are going to be small. They won’t be on a grand, industrial…